{"url":"https://lda.senate.gov/api/v1/filings/1f643fef-2795-453a-a2b4-d8a6fb2bbc40/","filing_uuid":"1f643fef-2795-453a-a2b4-d8a6fb2bbc40","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2021,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/1f643fef-2795-453a-a2b4-d8a6fb2bbc40/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"HWM III","dt_posted":"2022-01-22T09:57:18.243000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"24 Dockside Lane #500","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Key Largo","registrant_state":"FL","registrant_zip":"33037","registrant":{"id":401105070,"url":"https://lda.senate.gov/api/v1/registrants/401105070/","house_registrant_id":null,"name":"GOVERNMENT COUNSEL, LLC","description":"Government advisory firm","address_1":"24 Dockside Lane #500","address_2":null,"address_3":null,"address_4":null,"city":"Key Largo","state":"FL","state_display":"Florida","zip":"33037","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"H.W. MENN","contact_telephone":"+1 202-235-5613","dt_updated":"2026-07-20T11:52:00.384413-04:00"},"client":{"id":203130,"url":"https://lda.senate.gov/api/v1/clients/203130/","client_id":12,"name":"APOTEX CORPORATION","general_description":"Generic pharmaceutical manufacturer","client_government_entity":false,"client_self_select":null,"state":"FL","state_display":"Florida","country":"US","country_display":"United States of America","ppb_state":"FL","ppb_state_display":"Florida","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-02-01"},"lobbying_activities":[{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Policies relating to strengthening domestic manufacturing of active pharmaceutical ingredients and finished dosages.","foreign_entity_issues":"Aposherm Inc. and Apotex Holdings Inc., parent companies of Apotex Corp. identified on the LD-1, have direct or indirect interests in companies that develop, manufacture, and/or sell generic drugs and therefore are interested in the issues identified in this report.","lobbyists":[{"lobbyist":{"id":71402,"prefix":null,"prefix_display":null,"first_name":"HENRY","nickname":null,"middle_name":"W","last_name":"MENN","suffix":"iii","suffix_display":"III"},"covered_position":"Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.","new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.2910 - Expanding Access to Low-Cost Generics Act of 2021; S. 2740-Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act; H.R. 5376-Build Back Better Act.","foreign_entity_issues":"Aposherm Inc. and Apotex Holdings Inc., parent companies of Apotex Corp. identified on the LD-1, have direct or indirect interests in companies that develop, manufacture, and/or sell generic drugs and therefore are interested in the issues identified in this report.","lobbyists":[{"lobbyist":{"id":71402,"prefix":null,"prefix_display":null,"first_name":"HENRY","nickname":null,"middle_name":"W","last_name":"MENN","suffix":"iii","suffix_display":"III"},"covered_position":"Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.","new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}